---
title: "XSNX.US (XSNX.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/XSNX.US/news.md"
symbol: "XSNX.US"
name: "XSNX.US"
parent: "https://longbridge.com/zh-HK/quote/XSNX.US.md"
datetime: "2026-03-13T20:51:00.735Z"
locales:
  - [en](https://longbridge.com/en/quote/XSNX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/XSNX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/XSNX.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/XSNX.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/XSNX.US/news.md)


# XSNX.US (XSNX.US) — 相關新聞

### [](https://longbridge.com/zh-HK/news/279088681.md)
*2026-03-13T20:24:14.000Z*
> The Centers for Medicare & Medicaid Services announced that manufacturers will participate in the third Medicare negotia

### [Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes](https://longbridge.com/zh-HK/news/279086023.md)
*2026-03-13T19:16:59.000Z*
> Defiance ETFs has filed to launch a new biopharma-focused ETF, pledging to donate 100% of its net advisory profits for t

### [Neil Laird Exits NovAccess Global, Joins Ondas Holdings](https://longbridge.com/zh-HK/news/210480573.md)
*2024-08-01T14:30:10.000Z*
> An update from NovAccess Global (XSNX) is now available. Neil J. Laird has stepped down as CFO of NovAccess Global Inc. 

### [NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit](https://longbridge.com/zh-HK/news/103615426.md)
*2023-12-01T21:55:01.000Z*
> (marketscreener.com) NovAccess Global Inc. announced today it will be presenting at the December 7th, 2023 virtual Inves

### [NovAccess Global : to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day](https://longbridge.com/zh-HK/news/92531559.md)
*2023-07-13T08:57:02.000Z*
> (marketscreener.com) NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day

### [NovAccess Global : Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements](https://longbridge.com/zh-HK/news/87391972.md)
*2023-05-11T09:07:11.000Z*
> (marketscreener.com) NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advanc

### [NovAccess Global : Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award](https://longbridge.com/zh-HK/news/82456982.md)
*2023-03-15T12:10:18.000Z*
> (marketscreener.com) Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award Cleveland

### [NovAccess Global to Present at World Orphan Drug Congress](https://longbridge.com/zh-HK/news/80170528.md)
*2023-02-16T01:00:00.000Z*
> CLEVELAND, OH / ACCESSWIRE / February 16, 2023 / NovAccess Global Inc.(OTCQB:XSNX), a biomedical company developing nove

### [NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress](https://longbridge.com/zh-HK/news/79126224.md)
*2023-02-03T01:00:00.000Z*
> Dr.Christopher Wheeler, NovAccess Lead Scientist, to Receive Leadership Award for his ContributionsCLEVELAND, OH / ACCES

### [NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate](https://longbridge.com/zh-HK/news/74168414.md)
*2022-11-22T00:00:00.000Z*
> Topic: Benefits of Immunotherapies Versus Conventional Chemotherapy for Patients and Their Support NetworksCLEVELAND, OH